Simulations Plus to Participate in the Stephens Annual Investment Conference
06 Novembro 2024 - 10:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a
leading provider of biosimulation, simulation-enabled performance
and intelligence solutions, and medical communications to the
biopharma industry, today announced that Shawn O’Connor, chief
executive officer, will participate in a fireside chat at the
Stephens Annual Investment Conference in Nashville, TN, on
Wednesday, November 20, 2024, at 12:00 p.m. Eastern Time. In
addition, Mr. O’Connor will host one-on-one meetings with investors
throughout the day.
The live audio webcast of Mr. O’Connor’s fireside chat can be
accessed via this link and also on the Investors page of the
Simulations Plus website where the replay will be available for 90
days following the event.
About Simulations Plus
With more than 25 years of experience serving clients globally,
Simulations Plus stands as a premier provider in the biopharma
sector, offering advanced software and consulting services that
enhance drug discovery, development, research, clinical trial
operations, regulatory submissions, and commercialization. Our
comprehensive biosimulation solutions integrate artificial
intelligence/machine learning (AI/ML), physiologically based
pharmacokinetics, physiologically based biopharmaceutics,
quantitative systems pharmacology/toxicology, and population PK/PD
modeling approaches. We also deliver simulation-enabled performance
and intelligence solutions alongside medical communications support
for clinical and commercial drug development. Our cutting-edge
technology is licensed and utilized by leading pharmaceutical,
biotechnology, and regulatory agencies worldwide. For more
information, visit our website at www.simulations-plus.com. Follow
us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts
where we can have the most positive impact. To learn more about our
latest initiatives and priorities, please visit our website to read
our 2023 ESG update.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241106293615/en/
Investor Relations Contacts: Lisa Fortuna Financial
Profiles 310-622-8251 slp@finprofiles.com
Cristin Ryman Simulations Plus Investor Relations 984-444-8358
cristin.ryman@simulations-plus.com
Simulations Plus (NASDAQ:SLP)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Simulations Plus (NASDAQ:SLP)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
